Dark

Check out our Level2View

GWPH
GW Pharmaceuticals Plc
stock NASDAQ

Inactive

May 4, 2021

218.96USD-0.146%(-0.32)1,464,939

Pre-market

0.00USD-100.000%(-219.28)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Dec 16, 2021

10:01AM EST Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment Benzinga

Nov 9, 2021

06:54PM EST Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance Benzinga

Jul 29, 2021

02:04PM EDT Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So. Benzinga

Jul 7, 2021

02:38PM EDT Nextleaf Solutions Forges Unique Path in the Cannabis Industry with its IP Strategy Benzinga

Jul 6, 2021

04:04PM EDT The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More Benzinga

Jul 2, 2021

12:42PM EDT Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June Benzinga

Jun 9, 2021

03:02PM EDT Cannabis Investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce Benzinga

May 11, 2021

12:38PM EDT The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More Benzinga

May 6, 2021

10:45AM EDT Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio Benzinga

May 5, 2021

09:27AM EDT Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc PR Newswire

09:27AM EDT Jazz Pharma Completes Acquisition Of GW Pharma RTTNews

May 4, 2021

03:09PM EDT Study: U.K. Cannabis Industry Could Be Worth $2.8B Per Year If These Problems Are Fixed Benzinga

08:10AM EDT The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data Benzinga

Apr 27, 2021

07:41AM EDT The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout Benzinga

Apr 23, 2021

04:02PM EDT GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals Benzinga

04:01PM EDT GW Pharmaceuticals Shareholders Approve Acquisition by Jazz GlobeNewswire Inc

Apr 20, 2021

08:07AM EDT The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex Benzinga

07:17AM EDT GW Pharmaceuticals Announces Co. Has 'received European Commission approval for EPIDYOLEX (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex' Benzinga

06:30AM EDT Tuberous sclerosis complex (TSC) represents a third indication for GWs cannabidiol in Europe GlobeNewswire Inc

Apr 16, 2021

08:01AM EDT The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs Benzinga

Apr 13, 2021

08:37AM EDT GW Pharmaceuticals And US Subsidiary Greenwich Biosciences To Present Data At 2021 American Academy Of Neurology Annual Meeting Apr. 17-22 Benzinga

08:30AM EDT EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies GlobeNewswire Inc

Mar 30, 2021

08:06AM EDT The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings Benzinga

Mar 26, 2021

04:39PM EDT Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference Benzinga

Mar 23, 2021

01:25PM EDT Samantha Gleit Behind Debt Structure In Today's Cannabis Industry Benzinga

Mar 5, 2021

03:42PM EST Three Ways To Approach The Cannabis Trade Benzinga

03:02PM EST Driven By Stem, a Vertically Integrated, Farm-to-Home, DaaS Platform Upticking the Future of the Cannabis Industry in 2021 Benzinga

09:30AM EST Driven By Stem Is A DaaS Platform Designed For The Future Of The Cannabis Industry Benzinga

Mar 2, 2021

09:57AM EST Lexaria Bioscience Corp. is Changing the Future of Drug Delivery Benzinga

Feb 26, 2021

12:32PM EST GW Pharmaceuticals' Epidyolex Wins EU Positive Opinion For Seizures Disorder Benzinga

10:12AM EST Investors Have Been Flocking To This US Cannabis ETF Benzinga

10:06AM EST Item 9 Labs and Why Franchising is the Growth Vehicle to Propel the Cannabis Industry Benzinga

10:04AM EST Investors Have Been Flocking To This U.S. Cannabis ETF Benzinga

07:17AM EST GW Pharma Reports Positive CHMP Opinion For Epidyolex For Use Of Treatment As Seizures Associated With Tuberous Sclerosis Complex Benzinga

07:15AM EST GW Pharmaceuticals receives positive CHMP opinion for GlobeNewswire Inc

Feb 22, 2021

05:14PM EST Cannabis Industry Set For More Consolidations In 2021 Benzinga

Feb 19, 2021

05:15PM EST The Week In Cannabis: Verano, Tilray, Sundial, Chris Webber, And More Benzinga

Feb 17, 2021

05:25PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds EGOV, GRNV, LACQ, and GWPH Shareholders PR Newswire

01:21PM EST INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on PR Newswire

Feb 16, 2021

01:02PM EST Mid-Day Market Update: Gold Slides Further, GW Pharma Reports Topline Growth Benzinga

08:23AM EST GW Pharmaceuticals: Q4 Earnings Insights Benzinga

07:19AM EST GW Pharmaceuticals Q4 EPS $(0.08) Down From $(0.07) YoY, Sales $148.20M Up From $109.08M YoY Benzinga

07:00AM EST Total revenue of $148.2 million for the fourth quarter and $527.2 million for the full year GlobeNewswire Inc

Feb 12, 2021

09:01PM EST SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GW PR Newswire

03:43PM EST Issuer Direct Evolution: The Power Of Reliable Content, Virtual Events, Communication And Storytelling Benzinga

06:20AM EST Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders PR Newswire

Feb 10, 2021

04:23PM EST The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma's GWPH Acquisition, Potential Federal Moves Benzinga

03:02PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds LACQ, VCVC, GWPH, and PRSP Shareholders PR Newswire

Feb 7, 2021

12:00PM EST Lifshitz Law Firm, P.C. Announces Investigation of CNIG, GWPH, JAZZ, HOL, JWS, PR Newswire

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

08:54AM EST Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: GlobeNewswire Inc

Feb 5, 2021

04:21PM EST The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma's GWPH Acquisition, Potential Federal Moves Benzinga

Feb 4, 2021

11:19AM EST GW PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GW Pharmaceuticals plc - GWPH Business Wire

11:18AM EST Moore Kuehn Encourages FST, GWPH, HOL, and VIE Investors to Contact Law Firm PR Newswire

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2021 Benzinga

09:00AM EST 10 Biggest Price Target Changes For Thursday Benzinga

07:22AM EST The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs Benzinga

07:04AM EST Morgan Stanley Downgrades GW Pharmaceuticals to Equal-Weight, Raises Price Target to $220 Benzinga

06:51AM EST INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on PR Newswire

06:09AM EST HC Wainwright & Co. Downgrades GW Pharmaceuticals to Neutral, Raises Price Target to $220 Benzinga

06:00AM EST A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Earnings, Jobless Claims Data Benzinga

05:15AM EST SVB Leerink Downgrades GW Pharmaceuticals to Market Perform, Raises Price Target to $220 Benzinga

Feb 3, 2021

05:33PM EST SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GlobeNewswire Inc

04:46PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates GW Pharmaceuticals plc PR Newswire

02:54PM EST Mid-Afternoon Market Update: Dow Gains 75 Points; GW Pharmaceuticals Shares Jump On Acquisition News Benzinga

01:25PM EST GWPH Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GW Pharmaceuticals plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - GWPH Business Wire

12:53PM EST Mid-Day Market Update: Crude Oil Rises Over 2%; Vaxart Shares Plummet Benzinga

12:15PM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of GW Pharmaceuticals plc (NASDAQ: GWPH) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by Jazz Pharmaceuticals plc (NASDAQ: JAZZ). GlobeNewswire Inc

11:29AM EST Needham Downgrades GW Pharmaceuticals to Hold Benzinga

11:21AM EST Mid-Morning Market Update: Markets Mixed; Alphabet Beats Q4 Expectations Benzinga

09:53AM EST Shares of GW Pharmaceuticals plc (GWPH) are currently gaining nearly 50% after Jazz Pharmaceuticals announced it will buy the cannabis biotech company for $7.2 billion. RTTNews

09:07AM EST Zogenix Shares Up 21% In Sympathy Following Jazz Pharma/GW Pharma Deal; Mizuho Says Deal Has 'Positive Read Through' To Zogenix; Firm Maintains Buy Rating, $55 Price Target On Zogenix Benzinga

08:30AM EST Alan Brochstein, The 420 Investor, Says On Benzinga's PreMarket Prep Says Thinks We're Going To See 'A Lot Of Development' In Cannabis Science; Highlight's GW Pharmaceuticals FDA Clearance Benzinga

08:10AM EST Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Feb. 3, 2021: FDX, TER, APHA, TAST, ARTL Benzinga

08:09AM EST Jazz To Acquire Cannabinoid Drug Company GW Pharma For $7.2B Benzinga

07:35AM EST Jazz To Acquire GW Pharmaceuticals For Total Consideration Of $7.2 Bln, Or $6.7 Bln Net Of GW Cash RTTNews

07:31AM EST GW Pharma Shares Were Previously Halted With News Pending Benzinga

07:31AM EST UPDATE: Jazz To Buy GW Pharma For $200/Share In Cash, $20 In Jazz Shares For Total Consideration Of $7.2B Benzinga

07:31AM EST Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, PR Newswire

07:31AM EST Jazz Pharma To Buy GW Pharma For $220/ADS In Cash, Shares Benzinga

Jan 29, 2021

05:14PM EST Cannabis Stock Gainers And Losers From January 29, 2021 Benzinga

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 27, 2021

10:07AM EST Stocks That Hit 52-Week Highs On Wednesday Benzinga

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 16, 2021

09:25AM EST The Week In Cannabis: Stocks Spike By Double Digits On Earnings, Strong Sales, Financings Benzinga

Jan 11, 2021

07:14AM EST GW Pharmaceuticals Sees Prelim. Q4 Sales ~$148M vs $140.44M Est., Sees Prelim. FY20 Sales ~$526M vs $519.52M Est. Benzinga

07:00AM EST GW Pharmaceuticals Provides Preliminary Fourth Quarter and GlobeNewswire Inc

Jan 7, 2021

10:58AM EST Why Nextleaf Solutions Is Betting That Patents Are The Future Of Cannabis Benzinga

Jan 5, 2021

12:24PM EST In a release issued earlier today byGW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group) under the same headline, please note the time of the conference and breakout session have changed. The conference will be held Tuesday, January 12, 2021 at 10:00 am ET (7:00 am PT). The breakout session will follow at 10:20 am ET (7:20 am PT). Complete corrected release follows: GlobeNewswire Inc

07:30AM EST GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan GlobeNewswire Inc

Dec 29, 2020

11:16AM EST Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week Benzinga

11:02AM EST Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week Benzinga

Dec 24, 2020

02:05PM EST The Week In Cannabis: Epidiolex, Casa Verde, FDA, Michigan, Colombia, And More Benzinga

Dec 21, 2020

11:31AM EST JAMA Neurology Publishes Phase 3 Study Of EPIDIOLEX Oral Solution In Patients With Seizures Associated With Tuberous Sclerosis Complex Benzinga

11:30AM EST JAMA Neurology Publishes Phase 3 Study of EPIDIOLEX GlobeNewswire Inc

Dec 7, 2020

07:00AM EST GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Needham Virtual Epilepsy & Pain Specialty CNS Therapeutics Conference on Thursday, December 10, 2020 at 11:00am EST. GlobeNewswire Inc

Dec 2, 2020

07:35AM EST The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga

Dec 1, 2020

08:34AM EST Greenwich Biosciences To Present Data On EPIDIOLEX Oral Solution At American Epilepsy Society Annual Meeting Benzinga

08:30AM EST - Meeting Highlights Include New Long-Term Data in Tuberous Sclerosis Complex - GlobeNewswire Inc

Nov 30, 2020

07:32AM EST GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 at 1:50 pm EST. GlobeNewswire Inc

Nov 13, 2020

08:31AM EST GW Pharmaceuticals Subsidiary Greenwich Biosciences To Present Analysis Of Three Clinical Studies Of Nabiximols For People With Multiple Sclerosis Related Spasticity At The American Academy Of Physical Medicine And Rehabilitation (AAPM&R) Annual Assembly Benzinga

08:30AM EST - Results from analysis of three Phase 3 clinical studies showed statistically significant improvement in spasticity in people with multiple sclerosis GlobeNewswire Inc

Nov 9, 2020

09:40AM EST The Week In Cannabis: Big Policy Wins Drive Stocks Up Benzinga

07:30AM EST GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Stifel Virtual Healthcare Conference on Wednesday, November 18, 2020 at 1:20 pm EST. GlobeNewswire Inc

Nov 7, 2020

05:22PM EST The Week In Cannabis: Big Policy Wins Drive Stocks Stocks Up Benzinga

Nov 3, 2020

03:06PM EST GW Pharmaceuticals Revenue Hits $137M, Tests Another Cannabis Plant-Based Drug Benzinga

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

07:31AM EST GW Pharmaceuticals Q3 EPS $(0.03) Beats $(0.83) Estimate, Sales $137.10M Beat $127.37M Estimate Benzinga

07:30AM EST - Total revenueincreased 51 percent to $137.1 million- Epidiolex for seizures associated with TSC launched in the U.S.-- Nabiximols Phase 3 program in MS spasticity now recruiting -- Conference call today at 830 a.m. EST - GlobeNewswire Inc

07:20AM EST GW Pharmaceuticals Initiates Pivotal Phase 3 Study Of Nabiximols For Multiple Sclerosis-Associated Spasticity Benzinga

07:15AM EST GW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols GlobeNewswire Inc

04:07AM EST Earnings Scheduled For November 3, 2020 Benzinga

Nov 2, 2020

10:18AM EST A Preview Of GW Pharmaceuticals's Earnings Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 22, 2020

10:34AM EDT GW Pharmaceuticals plc to Report Financial Results and Operational GlobeNewswire Inc

Oct 21, 2020

08:00AM EDT -- Technology provides a newway for the community to communicate and connect -- GlobeNewswire Inc

Oct 15, 2020

10:52AM EDT Cramer Weighs In On Shopify, TJX Companies And More Benzinga

Oct 13, 2020

02:00PM EDT New CBD Rules In Australia Bode Well For Overall Market, Observers Say Benzinga

Sep 29, 2020

01:02PM EDT Peltz's Departure From Aurora Sends Shockwaves Though Cannabis Stocks Benzinga

Sep 23, 2020

05:56AM EDT GW Pharmaceuticals Receives Australian Therapeutic Goods Administration Approval for Epidyolex for the Treatment of Seizures in Patients With Two Rare, Severe Forms of Childhood-onset Epilepsy Benzinga

04:01AM EDT GW Pharmaceuticals Gets Australian Therapeutic Goods Administration Approval For EPIDYOLEX RTTNews

03:54AM EDT GW Pharmaceuticals receives Australian Therapeutic Goods GlobeNewswire Inc

Sep 10, 2020

04:03PM EDT GW Pharma Reports Its Greenwich Biosciences Subsidiary To Present Results Of Survey Highlighting Prevalence Of Cannabis Use Among People With Multiple Sclerosis Benzinga

04:00PM EDT - Results from post-hoc analysis of phase 3 clinical study show nabiximols was well-tolerated and provided continued reductions in spasticity for individuals who remained on therapy GlobeNewswire Inc

04:00PM EDT Greenwich Biosciences to Share Results of Cannabis Use Survey GlobeNewswire Inc

Sep 2, 2020

11:30AM EDT 3 Pharma Stocks That Are COVID-19 Resistant Benzinga

Sep 1, 2020

07:00AM EDT GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GWs Chief Executive Officer, will present a business update at the following virtual investor conferences: GlobeNewswire Inc

Aug 31, 2020

01:06PM EDT Pharmaceutical Companies Are Doing Much More Than Battling COVID-19 Benzinga

Aug 25, 2020

09:35AM EDT Benzinga's Top Upgrades, Downgrades For August 25, 2020 Benzinga

06:47AM EDT Raymond James Initiates Coverage On GW Pharmaceuticals with Market Perform Rating Benzinga

Aug 8, 2020

09:44AM EDT The Week In Cannabis: FDA Approves Epidiolex For TSC, Brett Favre Joins The Industry, Stocks In Red Benzinga

Aug 7, 2020

04:31PM EDT The Week In Cannabis: FDA Approves Epidiolex, Brett Favre Joins The Industry, Stocks In Red Benzinga

11:03AM EDT HC Wainwright & Co. Maintains Buy on GW Pharmaceuticals, Lowers Price Target to $162 Benzinga

06:36AM EDT Needham Maintains Buy on GW Pharmaceuticals, Lowers Price Target to $180 Benzinga

Aug 6, 2020

04:44PM EDT GW Pharmaceuticals: Q3 Earnings Insights Benzinga

04:02PM EDT GW Pharmaceuticals Q3 EPS $(0.02) May Not Compare To $(0.63) Estimate, Sales $121.30M Beat $120.31M Estimate Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Aug 4, 2020

06:08AM EDT HC Wainwright & Co. Maintains Buy on GW Pharmaceuticals, Raises Price Target to $164 Benzinga

Aug 3, 2020

07:05AM EDT GW Pharmaceuticals Announces FDA Approval of EPIDIOLEX Oral Solution to Treat Seizures Benzinga

07:00AM EDT Age-range for all EPIDIOLEX indications expanded to include patientsone year of age and older GlobeNewswire Inc

Jul 28, 2020

07:54AM EDT Benzinga Pro's Top 5 Stocks To Watch For Tues., Jul. 28, 2020: MCD, AAPL, SBUX, SNGX, GWPH Benzinga

Jul 24, 2020

06:55AM EDT Cramer Weighs In On Trade Desk, DISH Network And More Benzinga

Jul 23, 2020

07:00AM EDT GW Pharmaceuticals plc to Report Financial Results and Operational GlobeNewswire Inc

Jul 17, 2020

12:27PM EDT Doctors Ethan Russo And Dale Hunt Join Robert Clarke To Launch Cannabis IP-Licensing Firm Benzinga

Jul 15, 2020

09:21AM EDT Stifel Downgrades GW Pharmaceuticals to Hold, Lowers Price Target to $140 Benzinga

Jul 14, 2020

05:12PM EDT Cannabis Stock Gainers And Losers From July 14, 2020 Benzinga

Share